breast cancer and semaglutide Breaking down findings of new study on weight loss drugs Popular weight loss drugs could

Comparable outcomes with Wegovy injection An indirect comparison between OASIS 4 and Novo Nordisks earlier STEP 1 trial, which evaluated injectable semaglutide (Wegovy), found the two formulations delivered comparable outcomes in weight reduction and improvements across key cardiometabolic markers

Recalls & Warnings November 03, 2025 Salmonella Outbreak Prompts Recall of Sams Club Members Mark Super Greens On October 31, 2025, the FDA announced a recall of all lots of Members Mark Super Greens dietary supplement powder after the supplement was linked to a multistate outbreak of Salmonella illness

Semaglutide, which is the active ingredient in Novo Nordisk's Wegovy and Ozempic, as well as tirzepatide, are considered GLP-1 drugs

1c), which may contribute to reported BWS hepatomegaly